We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Epidemiology Study in Major Orthopaedic Surgery

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00159185
First Posted: September 12, 2005
Last Update Posted: July 21, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
GlaxoSmithKline
Information provided by:
Hoersholm Hospital
  Purpose

The purpose of this study is to:

  • Create a database including a description of the patient population that undergoes total hip replacement with special emphasis on orthopedic and cardiovascular complications and the quality of life 1 year postoperatively.
  • Characterise the patient at risk for the above mentioned events
  • Create methods for predicting patients at risk for short-term (90 days) and long term (1 year) complications in relation to hip replacement surgery.

Condition
Thrombosis Postoperative Complications Quality of Life

Study Type: Observational
Study Design: Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Epidemiology Study in Major Orthopaedic Surgery

Further study details as provided by Hoersholm Hospital:

Estimated Enrollment: 500
Study Start Date: January 2004
Estimated Study Completion Date: May 2006
  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All patients operated with Hip Arthroplasty Replacement in Hillerød and Hørsholm Hospitals from 1.1 2004.

Exclusion Criteria:

  • Written informed consent denied
  • Patients under 18 years of age.
  • Patients not habitants of Denmark at the time of the operation.
  • Patients without a CPR-number (civil registration number).
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00159185


Locations
Denmark
Hoersholm Hospital
Hoersholm, Denmark, 2970
Sponsors and Collaborators
Hoersholm Hospital
GlaxoSmithKline
Investigators
Study Chair: Camilla Ryge, MD Hoersholm Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00159185     History of Changes
Other Study ID Numbers: ESMOS
First Submitted: September 9, 2005
First Posted: September 12, 2005
Last Update Posted: July 21, 2006
Last Verified: September 2005

Keywords provided by Hoersholm Hospital:
Arthroplasty, Replacement, Hip
Epidemiology

Additional relevant MeSH terms:
Thrombosis
Postoperative Complications
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Pathologic Processes